Skip to main navigation
Close
Main navigation
Advocacy
Issue Overview
#MarkupMadness
#Rx4Savings
#Rx4StateSavings
GDUFA/BsUFA User Fees
Build Back Better
State Legislation
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Meet Our Board
Social Commitment
Generic Medicines
Biosimilars
Careers
Contact Us
Stories
Events
Resources
All Resources
All Access Podcast
2021 Savings Report
2022 Voices of Access Report
Biosimilars Patient Resource Center
Supply Chain Blueprint
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Menu
AAM All Access Podcast
- AAM CEO Dan Leonard convenes industry and policy experts to explore why the Inflation Reduction Act (f/k/a Build Back Better) reduces generic and biosimilar competition.
Learn More
Close
Breadcrumb
Home
Resources
Press Releases
Press Releases
Share
Press Release
Aug 7, 2022
| Allen Goldberg
AAM Statement on Senate Passage of Inflation Reduction Act
Press Release
Jul 28, 2022
| Allen Goldberg
Association for Accessible Medicines (AAM) Elevates David Gaugh to Executive Vice President for Sciences & Regulatory Affairs
Press Release
Jul 6, 2022
| Allen Goldberg
AAM Statement on BBB 2.0
Press Release
Jun 6, 2022
| Allen Goldberg
Giuseppe Randazzo Joins AAM as Vice President, Sciences and Regulatory Affairs
Press Release
May 23, 2022
| Allen Goldberg
AAM Statement in Response to Federal Trade Commission Request for Information on PBM Business Practices
Press Release
May 16, 2022
| Allen Goldberg
Association for Accessible Medicines Names Craig Burton as Senior Vice President, Policy & Strategic Alliances, and Executive Director of the Biosimilars Council
Press Release
May 11, 2022
| Allen Goldberg
AAM Statement on House Energy and Commerce Health Subcommittee Markup of H.R. 7667 Reauthorizing Generic Drug and Biosimilar User Fee Amendments
Press Release
Apr 1, 2022
| Rachel Schwartz
HHS Finds Biosimilars Use Results in “Significant Spending Reduction” For Medicare and Its Beneficiaries
Press Release
Feb 15, 2022
| Rachel Schwartz
AAM Statement on the Confirmation of Robert Califf to Lead FDA
Press Release
Feb 15, 2022
| Rachel Schwartz
Academy of Managed Care Pharmacy Named AAM’s 2022 Champion of Access
Press Release
Feb 14, 2022
| Rachel Schwartz
Chirag Patel Named Chair of the Association for Accessible Medicines Board of Directors
Press Release
Feb 14, 2022
| Rachel Schwartz
AAM Announces 2022 Board of Directors
Load More
Advocacy
Issue Overview
#MarkupMadness
#Rx4Savings
#Rx4StateSavings
GDUFA/BsUFA User Fees
Build Back Better
State Legislation
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Meet Our Board
Social Commitment
Generic Medicines
Biosimilars
Careers
Contact Us
Stories
Events
GRx+Biosims 2022
Access! 2022
Resources
All Resources
All Access Podcast
2021 Savings Report
2022 Voices of Access Report
Biosimilars Patient Resource Center
Supply Chain Blueprint
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action